(PharmaNewsWire.Com, November 03, 2024 ) The Antimicrobial Susceptibility Testing Market is experiencing growth due to rising concerns over antibiotic resistance and infection control. AST systems help healthcare providers determine the most effective treatments for infections, improving patient outcomes. Key players are developing rapid, accurate testing methods to address the increasing prevalence of drug-resistant pathogens. Analysts forecast strong growth in the AST market, driven by heightened healthcare demands and advancements in diagnostic technology.
Maximize Market Research has also published the following reports:
The Bulgaria Epilepsy Treatment Market size was valued at USD 2475.39 Thousands in 2023 and the total Bulgaria Epilepsy Treatment Market revenue is expected to grow at a CAGR of 2.06 % from 2024 to 2030, reaching nearly USD 2855.17 Thousands.
The Phytoestrogen Supplements Market size was valued at USD 3.21 Billion in 2023 and the total Phytoestrogen Supplements Market size is expected to grow at a CAGR of 5.66% from 2024 to 2030, reaching nearly USD 4.72 Billion by 2030.
About Maximize Market Research
Maximize Market Research provides B2B and B2C research on 6,500 high-growth emerging opportunities and technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics and communications, Internet of Things, Food and Beverages, Aerospace and defense, and other manufacturing sectors.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
